新生児の免疫強化のためのワクチン接種戦略

Tobias R Kollmann¹, Arnaud Marchant², Sing Sing Way³

¹Systems Vaccinology, Telethon Kids Institute, Nedlands, WA 6009, Australia. tobias.kollmann@telethonkids.org.au marchant@ulb.be singsing.way@cchmc.org.

Science (New York, N.Y.)

|May 9, 2020

まとめ

新生児は感染リスクが高い. 母親のワクチン接種や広範な免疫刺激を含む新しいワクチン戦略は生命の脆弱な最初の数週間で新生児を保護することを目的としています

科学分野:

免疫学
新生児の健康
ワクチン学

背景:

新生児は感染症に非常に敏感で世界的な健康問題です
現在のワクチンは,発達不成熟のため,新生児の流行病原体を覆うことができないか,適切な保護を誘導することができない.
早期の脆弱性の窓は従来の予防接種を超えた新しい保護戦略を必要とします

研究の目的:

感染症に対する新生児の保護を強化するための代替ワクチン接種戦略を探求する.
病原体無知免疫刺激と受動的免疫移転のための母体ワクチンについて議論する.
新生児ワクチン学における知識のギャップを特定し,将来の研究方向性を概説する.

主な方法:

新生児の免疫とワクチン反応に関する現在の文献のレビュー.
提案された代替戦略の分析:病原体無知ワクチンと産前免疫.
妊産婦と新生児のワクチン接種を組み合わせるシナジスティックの可能性についての議論

主要な成果:

現存するワクチンは,新生児を主要な感染源から保護するのに不十分です.
母親のワクチン接種は免疫の受動的移転を促し幼児を臨界期の初期に保護します
病原体無知的なアプローチと組み合わせた戦略はより広範で即時の保護を約束しています

結論:

新生児感染の重荷に対処するには新種のワクチン接種戦略が不可欠です
母親の免疫と病原体無知的なアプローチは新生児の免疫を強化する有望な手段です
新生児の総合的な保護のためのこれらの戦略を最適化し統合するには,さらなる研究が必要です.

さらに関連する動画

08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.8K

05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

60.6K

関連する概念動画

Vaccinations

Development of Immunocompetence

664

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

664

01:31

Active versus Passive Immunity

9.6K

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...

9.6K

01:30

Pneumonia V: Nursing management and Prevention

3.3K

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

3.3K

01:29

Microorganisms in Medicine and Therapeutics

832

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

832

01:29

Drug Dosing: Infants and Children

172

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

172

関連する実験動画